APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.

Gastro-Intestinal System
Abnormal LFT Guidelines NENC Hepatology Network revised Nov 2016
Bariatric Prescribing and Monitoring Guidance for GPs V4
Prescribing Trans Anal Irrigation – guidelines for prescribing 2019 v2.0

Cardiovascular System
Angina GL (Updated 2014)
Atrial fibrillation – Prescribing for Non-valvular AF in Primary Care v2.0
Antiplatelet Guidelines – Mar 2017
Dronedarone SCG – Sept 17
FATS7 – Nov 2016
Hypertension Guidelines – 2017
Oral Anticoagulant Comparison v2.1 – Jan 2016  

Respiratory System
COPD management guidelines v2.0

Central Nervous system
Cognitive enhancing medication – leaflet for primary care v2.0
ADHD Adult shared care v1.0 Sept 2019
ADHD Children shared care Sept 2019 v1.0
Antipyschotic Leaflet September 2019 v2.0
Dexamfetamine, primary sleep disorders – Nov 2013

Headache Management Guidelines (Adult) – May 2016 Northern East Update, endorsed for use in North of Tyne and Gateshead areas – CURRENTLY UNDER REVIEW
Ketamine in Palliative Care Shared Care Guidelines – Aug 2017
Lithium-shared-care-update June 2019 v2.0
Melatonin – Children and Young People June 2018
Memantine information for primary care – Dec 17
Naltrexone SCG – May 2016
Vigabatrin SCG – Jul 2014

Infections and antibiotics
Nice Antimicrobial Guidance
Nebulised – Gentamicin Information-for-Primary-Care v2.0

Endocrine System
Denosumab Information leaflet 2018
Gender Dysphoria – Feminising Hormones – Mar 2017
Gender Dysphoria – Masculinising Hormones – Mar 2017
Thyroid Gudelines (TRAMP2) June 2018
Osteoporosis guidelines, including bisphosphonate review Dec 17
Liothyronine prescribing guidance v0.4

Genito-Urinary System
Erectile Dysfunction – Guidelines for the investigation and management of men with ED – Updated Sep 2015 – CURRENTLY UNDER REVIEW
Menopause guideline January 2019 v2.0
Non-Surgical Management of Overactive Bladder (OAB) pathway – Jan 2015
Urology Guideline – March 19
Methylphenidate for giggle incontinence – Children – July 2018
Catheter Formulary 2020 v1.0
Catheter info sheet v1.0

Renal Disease
Kidney Guidelines, NoT and Gateshead – CKD – Chronic Kidney Disease – Mar 2017

Malignant Disease and Immunosuppression
Guidelines for the Monitoring of Immune Modifying Drugs (IMDs) in Stable Adult Patients (excluding post transplantation in Primary and Secondary Care – July 2018
Immunosuppressive Treatment Following Liver Transplants SCG – Jun 2017
Immunosuppression following Paediatric renal transplantation SCG – Oct 17
Immunosuppressive Treatment following Renal Transplant – Dec 2016
Lanreotide and Octreotide July 2019 v2.0
Immunosuppressive Treatment for Paediatric Nephrotic Syndrome SCG – Oct 17
Tocilizumab-monitoring-shared-care-guidance-June-18 v1
NECN Palliative and End of Life Care guidelines 2016

Nutrition and Blood
Erythropoietin (Darbepoetin [Aranesp]) in the Treatment of Patients with CKD – Jul 17
Cinacalcet in primary hyperparathyroidism – 2020 final V4
Infant Formulae Prescribing Guidelines – Sep 2016
Vitamin D Quick reference guide v2.0
Vitamin B12 management v1.0

Musculoskeletal and Joint Diseases

Ear, Eyes, Nose and Throat
ENT Guideline – Feb 2017
Eye conditions – NoT & G Guidelines for the management of common Opthalmology Conditions – Sep 2016

Acne management Guidelines v2.1

Blood-glucose-monitoring-guideline v2.0
Diabetes Stepped Approach guideline Jan 2019

Other Guidance
Brand name prescribing guidance v1.0
Prescribing-intervals Jan 2019
Seven-day-Rx-and-Monitored-dosage-systems Jan 2019
Stoma Prescribing Guidelines North of Tyne APC – Jan 2016
Swallowing-difficulties v2.0
Third party ordering – January 2019 (expiry date extension)